NextPlat (NXPL) reported Q1 2026 earnings with total net revenues of $10 million, down from $14 million year-over-year. The healthcare segment showed a revenue of $7 million, while pharmacy contract revenue increased to $1.9 million. Consolidated gross profit rose to $3.4 million, with a gross margin of 35%. The company achieved a significant reduction in operating losses and is expanding healthcare services nationwide. Management confirmed a successful turnaround plan and is enhancing liquidity through an ATM equity program, although no immediate draw-downs are planned.